Related Experiment Videos
Live attenuated vaccines for human use.
1Swiss Serum and Vaccine Institute, Berne.
Current Opinion in Biotechnology
|June 11, 1992
Summary
Live attenuated vaccines are effective disease preventatives. Researchers are now using these vaccine strains as expression vectors for new antigens, with promising candidates in clinical trials.
Area of Science:
- Vaccinology
- Microbiology
- Molecular Biology
Background:
- Live attenuated vaccines have a proven history in preventing viral and bacterial infections.
- The development of novel vaccine strategies is crucial for combating emerging and re-emerging infectious diseases.
Purpose of the Study:
- To explore the use of live attenuated vaccine strains as expression vectors for heterologous antigens.
- To evaluate the potential of recombinant DNA technology in developing new vaccine candidates.
Main Methods:
- Utilizing established live attenuated vaccine strains.
- Employing recombinant DNA technology to insert genes encoding heterologous antigens.
- Developing novel vector systems for antigen expression.
Main Results:
- Several vaccine strains have been successfully modified to express cloned heterologous antigens.
- Candidate vaccine strains and vector systems have been generated.
Conclusions:
- Live attenuated vaccine vectors represent a promising platform for developing new vaccines.
- Ongoing clinical evaluations will determine the efficacy and safety of these novel vaccine candidates.